Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)

PHASE3CompletedINTERVENTIONAL
Enrollment

508

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Skin Infections, Bacterial
Interventions
DRUG

Retapamulin Ointment, 1%

Provided as approximately 10 grams of an off-white smooth ointment in collapsible aluminum tubes with reverse taper puncture tip caps.

DRUG

Placebo ointment

Provided as approximately 10 grams of an off-white smooth ointment in collapsible aluminum tubes with reverse taper puncture tip caps.

Trial Locations (54)

1

GSK Investigational Site, Midrand

81

GSK Investigational Site, Lynnwood

83

GSK Investigational Site, Hatfield

1501

GSK Investigational Site, Benoni

1657

GSK Investigational Site, Loma Hermosa

6045

GSK Investigational Site, Newton

6620

GSK Investigational Site, Chivilocoy

6850

GSK Investigational Site, Worcester

7530

GSK Investigational Site, Belville

7572

GSK Investigational Site, Cape Town

9460

GSK Investigational Site, Welkom

11218

GSK Investigational Site, Brooklyn

11229

GSK Investigational Site, Brooklyn

13057

GSK Investigational Site, East Syracuse

13790

GSK Investigational Site, Johnson City

15401

GSK Investigational Site, Uniontown

19401

GSK Investigational Site, Norristown

22180

GSK Investigational Site, Vienna

29615

GSK Investigational Site, Greenville

32401

GSK Investigational Site, Panama City

32712

GSK Investigational Site, Orlando

32960

GSK Investigational Site, Vero Beach

33023

GSK Investigational Site, Hollywood

33144

GSK Investigational Site, Miami

33155

GSK Investigational Site, Miami

33401

GSK Investigational Site, West Palm Beach

33441

GSK Investigational Site, Deerfield Beach

33606

GSK Investigational Site, Tampa

45246

GSK Investigational Site, Cincinnati

59701

GSK Investigational Site, Butte

60005

GSK Investigational Site, Arlington Heights

66160

GSK Investigational Site, Kansas City

70112

GSK Investigational Site, New Orleans

77036

GSK Investigational Site, Houston

80904

GSK Investigational Site, Colorado Springs

84010

GSK Investigational Site, Bountiful

85705

GSK Investigational Site, Tucson

90048

GSK Investigational Site, Los Angeles

90620

GSK Investigational Site, Irvine

92804

GSK Investigational Site, Anaheim

93710

GSK Investigational Site, Fresno

95825

GSK Investigational Site, Sacramento

226003

GSK Investigational Site, Lucknow

390001

GSK Investigational Site, Vadodara

442102

GSK Investigational Site, Wardha

560002

GSK Investigational Site, Bangalore

07666

GSK Investigational Site, Teaneck

CP1431FWO

GSK Investigational Site, Buenos Aires

C1180AAX

GSK Investigational Site, Buenos Aires

80240-280

GSK Investigational Site, Curitiba

80810-050

GSK Investigational Site, Curitiba/Paraná

99010-080

GSK Investigational Site, Passo Fundo

Unknown

GSK Investigational Site, Pune

GSK Investigational Site, Cape Town

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY